Related by context. All words. (Click for frequent words.) 80 GAAP EPS 79 adjusted EPS 77 diluted share 76 EPS 73 Diluted EPS 73 Non GAAP EPS 72 Adjusted EPS 71 Diluted earnings 69 Fully diluted earnings 69 Non GAAP diluted 68 FFO 68 Adjusted Diluted EPS 68 netincome 67 normalized FFO 67 Non GAAP net 67 Pro forma EPS 67 Net Income 67 adjusted EBITDA 67 Adjusted Earnings 67 Earnings Per Share 67 Fully diluted EPS 66 fully diluted 66 Normalized EPS 66 non GAAP 66 Adjusted diluted 66 pro forma EPS 66 #.# perdiluted 65 Pro forma diluted 65 EPADS 65 #.#/diluted share 65 Projected FFO 65 EBITDA 64 normalized EPS 64 earnings pershare 64 Non GAAP adjusted EBITDA 64 Net income 64 Adjusted EBITDA 64 Fully diluted 64 Exceptional Items 64 Normalized EBITDA 63 Consolidated Adjusted EBITDA 63 pro forma 63 per dilutedshare 63 Pro forma net 63 Pro Forma EPS 63 non recurring 63 Earnings 62 diluted 62 proforma EPS 62 pro forma EBITDA 62 DAC unlock 62 Pro forma Adjusted EBITDA 62 EBIT 62 Free Cash Flow 62 diluted weighted 62 pro forma adjusted EBITDA 62 pershare 62 #.#-#.# usd [002] 62 Diluted Earnings Per Share 62 Adjusted FFO 62 Non GAAP 61 items affecting comparability 61 DEPS 61 Core FFO 61 earnings 61 Normalised earnings 61 operating income1 61 EPS Guidance 61 share assuming dilution 60 Pro forma EBITDA 60 AFFO 60 FFO Per Share 60 FFO FFO 60 GAAP 60 per share1 60 diluted ADS 60 excluding nonrecurring items 60 FY# revs 60 Sees FY# EPS 59 GAAP Diluted EPS 59 Individual Annuities segment 59 amortization expense 59 EBITDA1 59 adjusted EBIT 59 continuingoperations 59 Including discontinued operations 59 Ps.#.# [006] 59 nonGAAP 59 EBDDT 59 FFOM 59 operatingincome 59 FY# EPS guidance 58 Consolidated EBITDAR 58 Comparable FFO 58 CFFO 58 non gaap 58 #.#-#.# excluding 58 Earning Per Share 58 #,# c [002] 58 Recurring FFO 58 Pro Forma EBITDA 58 Non GAAP Diluted EPS 58 SEK -#.# [001] 58 diluted HEPS 58 fiscal# 58 consolidated OIBDA 58 excluding nonrecurring 58 adj EPS 58 Earnings Guidance 58 Raises FY# EPS 58 Diluted Share 58 Non GAAP Adjusted EBITDA 58 2Q EPS 57 EBITDAS 57 Projected FFO per 57 = Diluted [019] 57 ended December# 57 EBITA 57 H1 FY# [001] 57 Pro forma 57 per MCFE 57 pro forma basis 57 SEK -#.# -#.# [001] 57 Adjusted 57 Operational EBITDA 57 Net Loss 57 Zacks Estimate 57 Items affecting comparability 57 nonroutine income 57 adopting SFAS #R 57 Consolidated OIBDA 57 #.#per diluted 57 SEK -#.# -#.# [003] 57 taxable equivalent FTE 57 loss allocable 57 EDITDA 57 LIFO adjustment 57 ATCF 57 Fourth Quarter Earnings Per 57 normalized EBIT 57 EBITDAX 57 OIBDA 57 adjusted EBITDAR 57 FY# EPS 57 Continuing Operations 57 Second Quarter Highlights 57 QUALCOMM pro forma 57 Adjusted Earnings Per 57 USD#.#m USD#.# per [001] 57 Normalized FFO 57 Adjusted EBITDA excludes 57 Q# revs 56 YTD# 56 diluted EPADS 56 discontinued operations 56 income allocable 56 EBITDAO 56 Excluding goodwill impairment 56 USD#.#m USD#.# per [002] 56 Diluted Earnings 56 Items impacting comparability 56 Earnings Per Diluted 56 HK#.# cents [001] 56 FFOPS 56 OP Unit 56 = Earnings [026] 56 Operating Cash Flow 56 profit beia 56 Reaffirms FY# EPS 56 #-# MMcfe d 56 DEPS guidance 56 BVPS 56 REBIT 56 Fully Diluted EPS 56 4Q FY# 56 Operating Income 56 adjusted HEPS 56 Items Affecting Comparability 56 millioncompared 56 Adjusted Basis 56 amortization OIBDA 56 Reaffirms Full 56 mainline CASM 56 Operations FFO 56 Adjusted EBIT 56 Consolidated EBITDA 56 EBITDAC 56 Loss Per Share 56 FFO payout ratio 56 Adjusted Pro Forma 56 Oxy ER 56 Forward Looking Guidance 56 Diluted 56 Quick Facts2 56 Lifts FY# EPS 55 noninterest expense totaled 55 standardized distributable cash 55 #.#per [002] 55 Unlevered Cash Flow 55 Backs FY# EPS 55 Adjusted FIFO EBITDA 55 EBITDA margin 55 EPS estimate 55 #,# =Jaegle 55 gross margin 55 nonrecurring items 55 thefourth quarter 55 #.#cps [002] 55 Diluted EPS Guidance 55 #.#/ADR 55 EUR -#.# [001] 55 n#.# [002] 55 Adjusted OIBDA 55 Sees FY# adj EPS 55 prioryear 55 Comparable EBITDA 55 ended September# 55 FAS CAS pension 55 DNOI 55 noninterest expense decreased 55 Q2 FY# [001] 55 OCF margin 55 antidilutive 55 Zacks Consensus Estimates 55 modestly accretive 55 Diluted EPS attributable 55 Significant Items 55 pretax 55 normalized EBITDA 55 EBITD 55 - Adjusted [030] 55 Pro forma adjusted EBITDA 55 debt extinguishments 55 SS NOI 55 Non IFRS 55 ascompared 55 nonoperating items 55 exclude noncash 55 MA PFFS 55 EBITA margin 55 diluted FAD 55 USD#.#m USD#.# [002] 55 OSIs 55 sees FY# EPS 55 Adjusted pro forma 55 Realized Earnings 55 Sees Q4 55 EBITDAA 55 NPAT 55 Recurring EBITDA 55 income1 55 adjusted ebitda 55 Segment EBIT 55 SFAS #R 55 excluding goodwill impairment 55 Ps.#.# [004] 55 Excluding discontinued operations 55 Before Unusual Items 55 adjusted distributable cash 54 adjusted EBITDAS 54 -dnj.com 54 HEPS 54 = Diluted [017] 54 Adjusted Operating 54 = Earnings [007] 54 retrospectively adjusted 54 Reiterates Guidance 54 Diluted FFO 54 Diluted HEPS 54 = Diluted earnings [009] 54 Pro Forma Adjusted 54 Qtr Qtr 54 invoiced shipment 54 OTTI charges 54 PBDIT 54 income teb 54 Weighted average diluted 54 contingently convertible securities 54 Q2 FY'# 54 Sees Q3 54 Adjusted EBT 54 Maintains FY# 54 Earnings Loss Per 54 noncash pretax charge 54 Adjusted EBITDAS 54 LBITDA 54 SEK#M 54 .#/share 54 Noninterest expense totaled 54 Exceeds Guidance 54 NOL utilization 54 Raises FY# 54 EBITDAF 54 No. #R 54 Q1 FY'# 54 Sees FY# revs 54 Affirms FY# 54 IAROC 54 endedSeptember 54 excluding exceptionals 54 #.#-#.# bln [007] 54 Reconciling Items 54 intangible impairment 54 EPS accretion 54 Pro Forma Adjusted EBITDA 54 DiaMed acquisition 54 Carrols Restaurant 54 Rs.#.# crores [006] 54 FY# Guidance 54 modestly dilutive 54 quarter# 54 excludes unrealized gains 54 Q3 FY'# 54 Provides FY# EPS 54 Excluding nonrecurring items 54 Prepaid ARPU 54 items impacting comparability 54 #E EPS 54 EPS ests 54 goodwill amortization 54 Statutory Accounts 54 F#Q# EPS 54 aftertax gain 54 Industrial CFOA 54 invoiced shipments 54 Non GAAP Earnings Per 54 EBT amounted 54 nine monthsended 54 #Q# EPS 54 Cuts FY# EPS 54 #.#c #.#c [002] 54 pretax goodwill impairment 54 TEB adjustment 54 CRIC shareholders 54 proforma basis 54 SEK -#.# [002] 54 adjusted Ebitda 54 Noninterest Expense Noninterest expense 54 - - Joanne Kempinger Demski 54 EPS Excl 54 months endedSeptember 53 Matches Estimate 53 Reaffirms Guidance 53 Medicare Advantage MLR 53 ninemonths 53 Backs FY# 53 Convertible Subordinated Debt 53 MNOK #.# 53 EUR #,# Mio 53 .# Per Share 53 = Diluted earnings [004] 53 netsales 53 heps 53 Fully Diluted Earnings Per 53 EBIT amounted 53 Items excluded 53 LIFO accounting 53 Q1 FY# EPS 53 EPS Rises 53 Pro forma FFO 53 CHF#.# billion [002] 53 Downstream CCS 53 Q#/FY# 53 EPADS estimates 53 Prepaid churn 53 = Diluted [023] 53 Boosts FY# 53 taxable equivalent 53 OPANA franchise 53 Assuming Dilution 53 NOL carryforwards 53 SEK -#.# -#.# [002] 53 assuming dilution 53 EBITANCE 53 No. #R SFAS 53 Income Per Share 53 distributable cash flow 53 #.#-#.# bln eur [003] 53 average assets ROAA 53 Goodwill Impairment Charge 53 Interest Expense Interest expense 53 EPADR 53 Lowers FY# EPS 53 = Diluted [033] 53 equity excluding AOCI 53 FIFO EBITDA 53 Partnered Brands segment 53 #.#/share [002] 53 cents ashare 53 f Represents 53 USD#.#m USD#.# [001] 53 adjusted1 net 53 upholstery fabrics segment 53 Sees Q2 53 Revises FY# EPS 53 FAS#R 53 NAREIT FFO 53 Non GAAP Disclosures 53 Guidance Raised 53 SSNOI 53 excluding BIBP 53 EBIT margin 53 adjusted OIBDA margin 53 Distributable Earnings 53 quarterended 53 F#Q# Earnings 53 FAS# R 53 Lifts FY# 53 QUALCOMM Strategic Initiatives 53 currency translation 53 loss NOL carryforward 53 Operating Profit 53 #.# = Diluted [001] 53 endedDecember 53 TEUR -# 53 Lifts Quarterly Dividend 53 = Income [004] 53 EPS accretive 53 Distributable Income 53 Modified EBITDA 53 Updates FY# EPS 53 normalized FFO guidance 53 excluding Alumbrera 53 = Diluted [021] 53 Adjusted EBITDA1 53 Cont Ops 53 Wireline adjusted EBITDA 53 Q2 adj 53 Sees FY 53 = Adjusted [002] 53 amortization EBITDA 53 Adjusted Ebitda 53 LIFO inventory valuation 53 From Continuing Operations 53 ASUR regulated 53 Visa MasterCard antitrust 53 #.#c #.#c [006] 53 #.#/BOE [002] 53 #.Net 53 Sees Q# 53 FQ1 EPS 52 Qualcomm Strategic Initiatives 52 Lifts FY# Revenue 52 Restructuring Charge 52 FAS #R 52 Scantron segment decreased 52 = Diluted [016] 52 Adjusted Operating Expenses 52 ROFE 52 = Diluted [022] 52 #.#ca [004] 52 FY# NPAT 52 Earnings Announcement Date 52 Normalised headline 52 EBTIDA 52 Unfavourable Changes 52 Consolidated Adjusted OIBDA 52 excluding reimbursables 52 distributable earnings 52 NYSE CHT Chunghwa 52 Pro forma adjustments 52 compensation expense 52 Gross Margin Gross 52 Selected GAAP Measures 52 Special Cash Dividend 52 = Diluted espokesman Dan Jiron 52 Adjusted EBTIDA 52 BioGlue revenues 52 Slashes FY# 52 Constant Currency 52 = Diluted [015] 52 Exterran stockholders 52 Backs FY# Revenue 52 Q3 revs 52 Common Share Dividend 52 assets ROAA 52 Zacks Consensus 52 PTOI 52 = Earnings [013] 52 Exchangeable Share Ratio 52 = Weighted average [026] 52 Adjusted Gross Profit 52 Nordson Corporation Declares 52 Second Quarter Dividend 52 RMB2 #.# 52 Fourth Quarter Dividend 52 capital employed ROACE 52 Q2 FY 52 taxes EBDDT 52 Normalised 52 = Earnings [027] 52 Chlor Alkali segment 52 Standardized distributable cash 52 EUR -#.# -#.# [001] 52 - - Diluted [008] 52 Chemicals Segment 52 CY# EPS 52 Net Profit 52 Guides Q3 52 Second Quarter Earnings Per 52 USD#.#m [008] 52 Negatively impacting 52 = Diluted [014] 52 adjusted1 52 c Calculated 52 Cents Vs 52 Net Loss Per 52 EBDT 52 Narrows Quick Facts 52 adjusted OIBDA 52 LIFO inventory adjustments 52 Compensation Expense 52 fullyear 52 Timeshare segment 52 = Diluted earnings [012] 52 excludes nonrecurring items 52 #.#-#.# vs 52 PDP MLR 52 Fiscal Quarter Earnings 52 Non GAAP Proforma 52 Reaffirms FY# 52 - - Diluted [003] 52 ROACE 52 Guides Q1 52 = Diluted earnings [007] 52 - Diluted 52 noncash goodwill impairment 52 noncash impairments 52 MNOK #,# 52 Reiterates FY# 52 EBDITA 52 F4Q 52 - - Net [055] 52 acquired Brooks Eckerd 52 Operational Results 52 Rs #.# lacs [002] 52 excluding divestments 52 ounces Ag eq 52 USGAAP 52 - - Diluted [007] 52 FY# EPS estimate 52 = Diluted earningsAll Dogfighters 52 RMB#.# [002] 52 nonrecurring 52 NET EARNINGS PER SHARE 52 distributable cash 52 Introductory teaser rates 52 Invested Capital ROIC 52 Revises FY# 52 SEK -# 52 Reported EBITDA 52 Net Loss Attributable 52 Realised Earnings 52 Q4 adj EPS 52 Earnings Per Common Share 52 Diluted EPS Diluted 52 #.#ma [005] 52 amortization EBITA 52 currency remeasurement 52 = Earnings [019] 52 early extinguishments 52 SG & 52 FFO allocable 52 revenues excluding nonrecurring 52 Tightens FY# 52 Forecast Quick Facts 52 excluding AOCI 52 Lifts FY# Earnings 52 = Earnings [001] 51 Weighted average shares 51 CAD payout ratio 51 Q4 LY 51 pension curtailment 51 = quarterback Spergon Wynn 51 AND ADJUSTED DILUTED EARNINGS 51 Non GAAP Adjusted 51 COMPUTATION 51 Q4 FY# [001] 51 DILUTED SHARE 51 Diluted Income Loss 51 Discretionary cash 51 dacetuzumab collaboration 51 adopting SFAS 51 MFFO 51 - -TheKnot.com 51 = Diluted [026] 51 JPY#.# billion [001] 51 PWOD 51 adjusted2 51 = Earnings [030] 51 fiscal year# 51 Weighted Average Shares 51 quarterof 51 Zacks Consensus Estimate 51 = Diluted [008] 51 F1Q 51 Adjusted Net 51 Taxable equivalent 51 = EMusei 51 LIFO provision 51 CASM decreased 51 SFAS# R 51 CASM excluding fuel 51 Boosts FY# EPS 51 FY# EPS Outlook 51 Revises Full 51 Q4 Adj 51 Fully Taxed EPS 51 = Diluted earnings [011] 51 NOK#.# [006] 51 MTM adj 51 #compared 51 Q3 EPS 51 Reaffirms FY# Revenue 51 #,#,# =Rayola Dougher senior 51 thequarter 51 EBIT Margin 51 Pretax 51 ESTIMATE FOR 51 FQ3 EPS 51 Fourth Quarter Results 51 = DilPIC#F 51 #.#x FY#E [002] 51 = Diluted [006] 51 unrealized derivative gain 51 Guidance Range 51 Diluted Earnings Loss Per 51 Guides Q# 51 = Diluted earniSivasubramaniam 51 Q4 F# 51 3Q FY# 51 Q1 EPS 51 annualized ROAE 51 Guides FY# 51 = DKey4Women 51 RMB#.# [009] 51 FSP EITF #-#-# [002] 51 Polymer Additives segment 51 = Non GAAP [003] 51 = Adjusted [001] 51 Full Year 51 Sees Q1 51 Lowers FY# 51 = Diluted [018] 51 #.# = Diluted [003] 51 Tikcro Technologies Reports 51 Unilin segment 51 EITF #-# [001] 51 unbilled revenue 51 - -PRW Staff 51 FSP APB #-# 51 Sees FY# 51 Asset Impairment Charge 51 GAAP Generally Accepted 51 Womacks Adjusted EBITDA 51 EARNINGS PER SHARE DILUTED 51 -Bond Index Etf 51 pretax noncash 51 Continuing Ops 51 = Earnings [018] 51 PER SHARE DILUTED 51 Increases Guidance 51 Guidance Quick Facts 51 = Diluted earnings [005] 51 EARNINGS IN RETROSPECT 51 proforma revenues 51 #.#/BOE [001] 51 US#.#m [002] 51 Core noninterest expense 51 Fabricated Products segment 51 Third Quarter Dividend 51 sameperiod 51 Vinyls segment 51 underlying NPAT 51 excluding QSI 51 EBTA 51 Reiterates FY# EPS 51 AOCF 51 MEUR -#.# 51 Euro#.# [003] 51 = Diluted [034] 51 9M FY# [002] 51 Per Diluted 51 Rmb#.# [006] 51 = DiluteAbdul Ghafoor Haideri 51 Based Compensation Expense 51 - -Jon Crowcroft 51 Net Interest Margin 51 = Diluted earnings [008] 51 - Adjusted [010] 51 Pretax Income 51 Forma Revenues 51 Income Applicable 51 Q1 F# 51 Comparable Basis 51 AirMedia shareholders 51 FQ4 EPS 51 Paperboard Packaging segment 51 Q4 FY# EPS 51 fuel CASM 51 Guides Q4 51 Three Month Periods 51 Equinix excludes 51 Amortization EBITDA 51 Q1 #F 51 Luminex NASDAQ LMNX 51 monthsended 51 Unusual Items section 51 Consolidated adjusted EBITDA 51 Pro Forma Condensed Consolidated 51 Reported ments 51 Non Controlling Interest 51 Ps.3 51 Backs FY# Adj 51 BUSINESS OUTLOOK 51 -Sheikh Mohammed Godolphin 51 - - Diluted [005] 51 proforma 51 beia 51 A#.# #.#c 51 adjusted EBITA 51 Discontinued operation 51 Distribution FAD 51 Normalized Earnings 51 Equity Investees 51 Q3 FY 51 Guides Q2 51 FY# adj 51 totaled BRL#.# 51 = Earnings [010] 51 Postpay ARPU 51 = DilutedG. Neeleman 51 ebita 51 = Diluted [030] 51 HealthStream Learning 51 FQ2 EPS 51 dilutive securities 51 CCPU 51 NOI decreased 51 retroactive reinstatement 51 Adjusted Non GAAP 51 MARRIOTT REVENUES totaled 51 Adjusted EBITA 51 Earnings Excluding Specified 50 asset valuation allowance 50 Pro Forma Net 50 LIFO inventory decrement 50 Reported Earnings Per 50 Reaffirms Fiscal 50 Normalized EBIT 50 Matches Consensus 50 amortization 50 Numerator Net income 50 NON RECURRING ITEMS 50 ANOI 50 SEK#.#m [001] 50 Misses Consensus 50 payout ratio 50 EPS GUIDANCE 50 =MAP Pharmaceuticals MAPP 50 FASB #R 50 - Net income 50 Record Fourth Quarter 50 - Non GAAP [009] 50 #.# =Atatahak 50 reports Q4 adj 50 = Earnings [009] 50 =Daggerhorn 50 -T#/T# 50 = Earnings [008] 50 average equity ROAE 50 LIFO expense 50 lowers FY# EPS 50 - - Earnunderwent resection 50 - - Net [047] 50 temporary impairments OTTI 50 noninterest expense 50 Net Tangible Assets 50 PV module shipments 50 Reaffirms Outlook 50 Non GAAP Basis 50 GBP#.#M [002] 50 PMPS brand 50 = Diluted [013] 50 Income Loss Per Share 50 accretive thereafter 50 -# TEUR 50 Headline earnings 50 GVIC consolidated 50 Consolidated EBITDA Margin 50 = Diluted [004] 50 Below Consensus 50 NYSE CEG ranks 50 thethird quarter 50 depreciation amortization depletion 50 date Wholesale Leathercraft 50 Fully Diluted 50 REVENUE Revenue 50 = Non GAAP [008] 50 = Weighted average [009] 50 = Earnings [006] 50 Invested assets 50 EBIT beia 50 Rs #.# lacs [001] 50 = Diluted [012] 50 EnPro consolidated 50 amortization Ebita 50 Arana Therapeutics Limited 50 1Q 2Q 50 Q4 FY 50 Narrows Guidance 50 Noninterest expense decreased 50 Schedules 2Q 50 Adjusted EBIDTA 50 SEK#.# [002] 50 OTTI charge 50 = Diluted [007] 50 Fully diluted weighted 50 option expensing 50 financialperformance 50 CORE EARNINGS PER SHARE 50 #.#/shr [002] 50 exclude nonrecurring items 50 USD#.#m [007] 50 EBIDTA 50 BioMarin Genzyme LLC 50 SUMMIT FINANCIAL GROUP INC. 50 RCOP 50 COMMON SHARES OUTSTANDING Basic 50 Cuts FY# 50 OIBA 50 Huarun minority interest 50 undepreciated assets 50 Surface Specialties acquisition 50 expenses totaled Ps 50 EARNINGS PER SHARE 50 inactive premarket 50 Misses Views 50 = Loss [007] 50 EUR#M EUR#M 50 Diluted #,#,# #,#,# [002] 50 Extra Ordinary Items 50 unaudited consolidated balance sheets 50 vs #.#m bt 50 YTD Fiscal 50 Profit Grows 50 sees FY# revs 50 - -Manvinder Singh 50 - Adjusted [022] 50 OIBDA margin 50 = Weighted average [003] 50 DVFA SG 50 - -Urnes 50 COGP 50 nonoperating expense 50 amortization EBIDTA 50 EARNINGS PER SHARE BASIC 50 GAAP EARNINGS 50 museum Julie Setlock 50 Payout Ratio 50 SFr#.# billion [002] 50 DILUTED #,#,# #,#,# [001] 50 #.# = Weighted [011] 50 comparedto 50 PER DILUTED SHARE 50 tax npat 50 H1 FY# [002] 50 =Kasasa Saver account 50 Fully Diluted Earnings 50 #.#/ADR increasing 50 aftertax 50 per mcfe 50 Cents Cents 50 Ag Eq oz 50 OPEB expense 50 Rs#.#mn [001] 50 noninterest expenses 50 SEK -#.# [003] 50 Items Impacting Comparability 50 Unaudited Condensed Consolidated 50 Tops Estimate 50 #.#-#.# mln vs. [001] 50 EPRA NAV 50 inventories revalued 50 partly franked 50 Of #.#p Vs [004] 50 Adjusted EBITDAX 50 ADJUSTED FOR 50 Technology NASDAQ WATG 50 F1Q EPS 50 = Net [002] 50 pre exceptionals 50 EARNINGS GUIDANCE 50 Dhs1 #m 50 - Adjusted [012] 50 EPADS estimate 50 Re.#.# 50 Saehan Bancorp Reports 50 Adjusted Diluted Earnings 50 Revises Guidance 50 LTM adjusted EBITDA 50 AutoZone repurchased 50 SPECIAL ITEMS 50 - Non Shane Germann 50 = Diluted earnings [001] 50 FAS CAS Pension 50 Proforma EBITDA 50 Order Backlog 50 Regular Quarterly Dividend 50 FINANCIAL HIGHLIGHTS IN THOUSANDS 50 thirdquarter 50 = Diluted [002] 50 Remains Inline 50 revenues teb 50 HK#.# cents [002] 50 = Diluted [036] 50 = Average [001] 50 Revises Q4 50 Confirms Guidance 50 SEK1 #m 50 EARNINGS PER SHARE Basic 50 convertible exchangeable 50 - - Non GAAP [008] 50 Q2 EPS 50 goodwill impairment 50 AmREIT Announces 50 = Adjusted [008] 50 Unallocated Corporate 50 Non GAAP Operating Margin 50 totaled USD#.#m 50 depreciation amortization 50 Gross margin 50 Non GAAP Measure 50 Q4 revs 50 theprior 50 Ebita margin 50 NON GAAP 50 Guides FY# EPS 50 = Net [018] 50 Adjusted Gross Margin 50 Backs FY# Earnings 50 FY# FY# EPS 50 Profit Rises Quick Facts 50 Visa indemnification 50 Distributable Cash 50 mainline CASM excluding 50 GAAP Adj 50 = Earnings [004] 50 Annualized ROE 50 excluding 50 Expense Adjustment 50 SEK #.#M #.# 50 rebased revenue 50 NET INCOME PER COMMON 50 Normalized Funds 50 Adjusted Operating Margin 50 Beats Estimate 50 goodwill impairment charge 50 Rs #.#mn 50 FIFO gross 50 = Earnings [015] 50 FINANCIAL RESULTS 50 secondquarter 50 #.#-#.# mln usd 50 REPORTS STRONG 50 NET INCOME TO NON 50 3Q 4Q 50 increaseof 50 Maintenance Capital Expenditures 50 Vishay stockholders 50 = Earnings [025] 50 Per Share Cash Dividend 50 #,#,# #,#,# Diluted [002] 50 #.#p #.#p [007] 50 DKK#.# [004] 50 Pharmacia Monsanto 49 Rs.#.#cr 49 Co. NYSE HNZ 49 unrealized derivative gains 49 #-# mln sfr 49 Diluted Common Share 49 DILUTED NET INCOME LOSS 49 Per Fully Diluted 49 Q3 FY# [001] 49 Operating netbacks 49 = Diluted [029] 49 View Quick Facts 49 Gross Addition CPGA 49 Updates Guidance 49 Scantron segment increased 49 Discontinued operations .# 49 9M FY# [001] 49 Och Ziff Funds 49 = Net [006] 49 mboepd 49 non GAAP1 49 Per Share Diluted 49 Increases Quarterly Cash Dividend 49 = WeightedNANNY MCPHEE RETURNS